Venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cause of cardiovascular mortality worldwide after myocardial infarction and stroke. Despite continuous progress in anticoagulation, a specific preventive strategy against VTE that goes beyond anticoagulation is still lacking. In recent years, it has been shown that arterial and venous thromboembolism share more common risk factors than previously thought, including dyslipidemia and inflammatory processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Case Report
Cutaneous myiasis caused by botfly larvae
- Chronic insomnia, REM sleep instability and emotional dysregulation
Risk factors for anxiety and depression
- Immune sensors
Dysfunctional signaling pathways in cardiomyocytes and their role in heart disease
- Inoperable NSCLC
Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy
- Dementia
Recognize incipient progression and identify countermeasures
- Subtype-specific risks and implications for neurological care
Suicidal tendencies in dementia
- Study report: Hidradenitis suppurativa
Comparison of rifampicin monotherapy with clindamycin/rifampicin combination
- From symptom to diagnosis